Aug 18, 2026 06:40AM
Aug 12, 2026 04:03PM
May 13, 2026 07:03AM
Apr 21, 2026 08:03AM
Apr 21, 2026 08:03AM
Apr 1, 2026 04:30PM
Apr 1, 2026 04:30PM Alto Neuroscience Reports Topline Data from Phase 2 Proof-of-Concept Study of ALTO-101 and Highlights Pipeline Advancements
Mar 16, 2026 06:03AM
Feb 13, 2026 08:04AM
Feb 13, 2026 08:04AM
Nov 17, 2025 05:35AM
Nov 12, 2025 07:57AM
Oct 24, 2025 06:49AM
Oct 20, 2025 10:59AM Alto Neuroscience (ANRO) PT Raised to $16 at Baird
Oct 20, 2025 07:03AM
Oct 20, 2025 07:03AM
Oct 20, 2025 07:01AM
Oct 20, 2025 07:01AM
Oct 3, 2025 07:34AM
Oct 3, 2025 07:34AM
Sep 22, 2025 10:02AM Important Notice to Long-Term Shareholders of Alto Neuroscience, Inc. (NYSE: ANRO); Brainstorm Cell Therapeutics Inc. (OTC: BCLI); Flywire Corporation (NASDAQ: FLYW); and Ibotta, Inc. (NYSE: IBTA): G
Jul 28, 2025 10:00AM
Jul 27, 2025 09:58AM
Jun 26, 2025 07:33AM
Jun 26, 2025 07:33AM
May 14, 2025 04:10PM
Apr 28, 2025 08:03AM
Sep 10, 2024 06:30AM Baird Reiterates Outperform Rating on Alto Neuroscience (ANRO)
Sep 9, 2024 03:36PM
Aug 13, 2024 04:05PM

330,011 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All